BACKGROUND: Carotenoids, micronutrients in fruits and vegetables, may reduce breast cancer risk. Most, but not all, past studies of circulating carotenoids and breast cancer have found an inverse association with at least one carotenoid, although the specific carotenoid has varied across studies. METHODS: We conducted a pooled analysis of eight cohort studies comprising more than 80% of the world's published prospective data on plasma or serum carotenoids and breast cancer, including 3055 case subjects and 3956 matched control subjects. To account for laboratory differences and examine population differences across studies, we recalibrated participant carotenoid levels to a common standard by reassaying 20 plasma or serum samples from each cohort together at the same laboratory. Using conditional logistic regression, adjusting for several breast cancer risk factors, we calculated relative risks (RRs) and 95% confidence intervals (CIs) using quintiles defined among the control subjects from all studies. All P values are two-sided. RESULTS: Statistically significant inverse associations with breast cancer were observed for α-carotene (top vs bottom quintile RR = 0.87, 95% CI = 0.71 to 1.05, P(trend) = .04), β-carotene (RR = 0.83, 95% CI = 0.70 to 0.98, P(trend) = .02), lutein+zeaxanthin (RR = 0.84, 95% CI = 0.70 to 1.01, P(trend) = .05), lycopene (RR = 0.78, 95% CI = 0.62 to 0.99, P(trend) = .02), and total carotenoids (RR = 0.81, 95% CI = 0.68 to 0.96, P(trend) = .01). β-Cryptoxanthin was not statistically significantly associated with risk. Tests for heterogeneity across studies were not statistically significant. For several carotenoids, associations appeared stronger for estrogen receptor negative (ER(-)) than for ER(+) tumors (eg, β-carotene: ER(-): top vs bottom quintile RR = 0.52, 95% CI = 0.36 to 0.77, P(trend) = .001; ER(+): RR = 0.83, 95% CI = 0.66 to 1.04, P(trend) = .06; P(heterogeneity) = .01). CONCLUSIONS: This comprehensive prospective analysis suggests women with higher circulating levels of α-carotene, β-carotene, lutein+zeaxanthin, lycopene, and total carotenoids may be at reduced risk of breast cancer.
BACKGROUND:Carotenoids, micronutrients in fruits and vegetables, may reduce breast cancer risk. Most, but not all, past studies of circulating carotenoids and breast cancer have found an inverse association with at least one carotenoid, although the specific carotenoid has varied across studies. METHODS: We conducted a pooled analysis of eight cohort studies comprising more than 80% of the world's published prospective data on plasma or serum carotenoids and breast cancer, including 3055 case subjects and 3956 matched control subjects. To account for laboratory differences and examine population differences across studies, we recalibrated participantcarotenoid levels to a common standard by reassaying 20 plasma or serum samples from each cohort together at the same laboratory. Using conditional logistic regression, adjusting for several breast cancer risk factors, we calculated relative risks (RRs) and 95% confidence intervals (CIs) using quintiles defined among the control subjects from all studies. All P values are two-sided. RESULTS: Statistically significant inverse associations with breast cancer were observed for α-carotene (top vs bottom quintile RR = 0.87, 95% CI = 0.71 to 1.05, P(trend) = .04), β-carotene (RR = 0.83, 95% CI = 0.70 to 0.98, P(trend) = .02), lutein+zeaxanthin (RR = 0.84, 95% CI = 0.70 to 1.01, P(trend) = .05), lycopene (RR = 0.78, 95% CI = 0.62 to 0.99, P(trend) = .02), and total carotenoids (RR = 0.81, 95% CI = 0.68 to 0.96, P(trend) = .01). β-Cryptoxanthin was not statistically significantly associated with risk. Tests for heterogeneity across studies were not statistically significant. For several carotenoids, associations appeared stronger for estrogen receptor negative (ER(-)) than for ER(+) tumors (eg, β-carotene: ER(-): top vs bottom quintile RR = 0.52, 95% CI = 0.36 to 0.77, P(trend) = .001; ER(+): RR = 0.83, 95% CI = 0.66 to 1.04, P(trend) = .06; P(heterogeneity) = .01). CONCLUSIONS: This comprehensive prospective analysis suggests women with higher circulating levels of α-carotene, β-carotene, lutein+zeaxanthin, lycopene, and total carotenoids may be at reduced risk of breast cancer.
Authors: Teresa T Fung; Frank B Hu; Susan E Hankinson; Walter C Willett; Michelle D Holmes Journal: Am J Epidemiol Date: 2011-08-10 Impact factor: 4.897
Authors: Joanne Kotsopoulos; Shelley S Tworoger; Hannia Campos; Fung-Lung Chung; Charles V Clevenger; Adrian A Franke; Christos S Mantzoros; Vincent Ricchiuti; Walter C Willett; Susan E Hankinson; A Heather Eliassen Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-03-23 Impact factor: 4.254
Authors: Deborah A Boggs; Julie R Palmer; Lauren A Wise; Donna Spiegelman; Meir J Stampfer; Lucile L Adams-Campbell; Lynn Rosenberg Journal: Am J Epidemiol Date: 2010-10-11 Impact factor: 4.897
Authors: Jaume Amengual; Glenn P Lobo; Marcin Golczak; Hua Nan M Li; Tatyana Klimova; Charles L Hoppel; Adrian Wyss; Krzysztof Palczewski; Johannes von Lintig Journal: FASEB J Date: 2010-11-24 Impact factor: 5.191
Authors: Yikyung Park; Louise A Brinton; Amy F Subar; Albert Hollenbeck; Arthur Schatzkin Journal: Am J Clin Nutr Date: 2009-07-22 Impact factor: 7.045
Authors: L Baglietto; K Krishnan; G Severi; A Hodge; M Brinkman; D R English; C McLean; J L Hopper; G G Giles Journal: Br J Cancer Date: 2010-12-14 Impact factor: 7.640
Authors: Joshua Petimar; Yong-Moon Mark Park; Stephanie A Smith-Warner; Teresa T Fung; Dale P Sandler Journal: Am J Clin Nutr Date: 2019-05-01 Impact factor: 7.045
Authors: A Heather Eliassen; Xiaomei Liao; Bernard Rosner; Rulla M Tamimi; Shelley S Tworoger; Susan E Hankinson Journal: Am J Clin Nutr Date: 2015-04-15 Impact factor: 7.045
Authors: Kevin Cohen; Ying Liu; Jingqin Luo; Catherine M Appleton; Graham A Colditz Journal: Breast Cancer Res Treat Date: 2017-02-11 Impact factor: 4.872
Authors: Julia S Sisti; Sara Lindström; Peter Kraft; Rulla M Tamimi; Bernard A Rosner; Tianying Wu; Walter C Willett; A Heather Eliassen Journal: Breast Cancer Res Treat Date: 2015-04-28 Impact factor: 4.872
Authors: Teresa T Fung; Stephanie E Chiuve; Walter C Willett; Susan E Hankinson; Frank B Hu; Michelle D Holmes Journal: Breast Cancer Res Treat Date: 2013-03-27 Impact factor: 4.872